Analysis of the CCR3 promoter reveals a regulatory region in exon I that binds GATA-I

被引:16
作者
Zimmermann, N [1 ]
Colyer, JL
Koch, LE
Rothenberg, ME
机构
[1] Childrens Hosp, Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
关键词
D O I
10.1186/1471-2172-6-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: CC Chemokine Receptor 3 (CCR3), the major chemokine receptor expressed on eosinophils, binds promiscuously to several ligands including eotaxins 1, 2, and 3. Even though the only cells that consistently accumulate following eotaxin administration in vivo are myeloid cells ( primarily eosinophils), other cell types have recently been shown to express CCR3. It is therefore important to elucidate the molecular mechanisms regulating receptor expression. Results: In order to define regions responsible for CCR3 transcription, a DNAse hypersensitive site was identified in the vicinity of exon 1. Coupled with our previous data implicating exon 1 in CCR3 transcription, we hypothesized that transcription factors bind to exon-1. Electrophoretic mobility shift analysis revealed that nuclear proteins in eosinophilic cells bound to exon 1. Furthermore, antibody interference and mutation studies demonstrated GATA-1 binding to exon 1. In order to test the 1.6-kb CCR3 promoter element ( that includes exon 1) for in vivo function, this region was used to generate transgenic mice that expressed a reporter protein. Strong transgene expression was achieved, with the pattern of expression suggesting a broad acting promoter. Conclusion: The transcription factor GATA-1 binds to CCR3 exon 1. The 1.6-kb CCR3 promoter element, that includes exon 1, is a strong promoter in vivo.
引用
收藏
页数:11
相关论文
共 52 条
  • [21] AN IMPROVED IMMUNOMAGNETIC PROCEDURE FOR THE ISOLATION OF HIGHLY PURIFIED HUMAN BLOOD EOSINOPHILS
    HANSEL, TT
    DEVRIES, IJM
    IFF, T
    RIHS, S
    WANDZILAK, M
    BETZ, S
    BLASER, K
    WALKER, C
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 145 (1-2) : 105 - 110
  • [22] THE COMPLETE NUCLEOTIDE-SEQUENCE OF THE HUMAN GONADOTROPIN-RELEASING HORMONE GENE
    HAYFLICK, JS
    ADELMAN, JP
    SEEBURG, PH
    [J]. NUCLEIC ACIDS RESEARCH, 1989, 17 (15) : 6403 - 6404
  • [23] GATA-1 REPROGRAMS AVIAN MYELOMONOCYTIC CELL-LINES INTO EOSINOPHILS, THROMBOBLASTS, AND ERYTHROBLASTS
    KULESSA, H
    FRAMPTON, J
    GRAF, T
    [J]. GENES & DEVELOPMENT, 1995, 9 (10) : 1250 - 1262
  • [24] Lee SC, 1999, J ALLERGY CLIN IMMUN, V103, pS194
  • [25] Eotaxin is required for the baseline level of tissue eosinophils
    Matthews, AN
    Friend, DS
    Zimmerrmann, N
    Sarafi, MN
    Luster, AD
    Pearlman, E
    Wert, SE
    Rothenberg, ME
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) : 6273 - 6278
  • [26] Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1
    McNagny, KM
    Sieweke, MH
    Döderlein, G
    Graf, T
    Nerlov, C
    [J]. EMBO JOURNAL, 1998, 17 (13) : 3669 - 3680
  • [27] Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers
    Menzies-Gow, A
    Ying, S
    Sabroe, I
    Stubbs, VL
    Soler, D
    Williams, TJ
    Kay, AB
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (05) : 2712 - 2718
  • [28] Motifs resembling hepatocyte nuclear factor 1 and activator protein 3 mediate the tissue specificity of the human plasminogen gene
    Meroni, G
    Buraggi, G
    Mantovani, R
    Taramelli, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (02): : 373 - 382
  • [29] Moriuchi H, 1997, J IMMUNOL, V159, P5441
  • [30] T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro
    Ochi, H
    Hirani, WM
    Yuan, Q
    Friend, DS
    Austen, KF
    Boyce, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (02) : 267 - 280